Government-Approved Quasi-Drug vs Cosmetic Hair Growth Formulas: Decoding Japanese Scalp Serum Labels in 2026

When you pick up a Japanese scalp serum, the label may carry terms like "medicated" or 医薬部外品 (quasi-drug). These classifications aren't marketing fluff; they reflect a government approval process that separates formulas allowed to make explicit efficacy claims from those that cannot. Understanding this divide helps you move past packaging promises and choose products grounded in the kind of evidence you actually care about.

At a glance: Quasi-drug vs cosmetic classification

What 'medicated' and 'quasi-drug' (医薬部外品) actually mean in Japan

In Japan's regulatory framework, a quasi-drug sits between a pharmaceutical (which treats disease) and a cosmetic (which beautifies or maintains appearance). To earn quasi-drug status, a manufacturer must submit formulation details, stability data, and evidence of efficacy to the Ministry of Health, Labour and Welfare. Approval is product-specific, not blanket, so each SKU undergoes its own review cycle. The payoff is explicit: the brand may print claims such as "prevents hair loss" or "promotes hair growth" on the label, language cosmetics cannot legally use.

Quasi-drug formulas must include at least one active ingredient drawn from a pre-approved list. Common actives in hair-growth quasi-drugs include:

• Minoxidil (less common in scalp serums, more in dedicated treatments)
• Adenosine (stimulates vascular endothelial growth factor in dermal papilla cells)
• β-Glycyrrhetinic acid (anti-inflammatory, soothes irritation)
• Dipotassium glycyrrhizinate (barrier support, reduces scalp sensitivity)
• Panthenyl ethyl ether (penetrates follicle, supports keratin synthesis)

The approval process is neither fast nor cheap. Brands invest months (sometimes over a year) in dossier preparation, third-party testing, and MHLW correspondence. That investment signals commitment, but it doesn't automatically translate to superior results for every user. What it does guarantee is that the product met a defined efficacy threshold under controlled conditions—much like how formulations are carefully developed with gentle, botanical ingredients to ensure they meet quality standards.

The cosmetic category: what these formulas can (and cannot) claim

Cosmetics in Japan operate under a lighter regulatory hand. No pre-market approval is required, though safety responsibility remains with the manufacturer. The trade-off is claim language: cosmetics may speak to maintenance, nourishment, or a healthy scalp environment, but they cannot promise prevention or treatment outcomes. Phrases like "supports thicker-looking hair" or "encourages a balanced scalp" fall within bounds; "prevents hair loss" does not.

That restriction doesn't mean cosmetic formulas are ineffective. Many rely on botanical extracts, amino acids, and hydrating actives that address the scalp environment indirectly, creating conditions where hair can grow without making a direct pharmacological intervention. The regulatory line is pragmatic: if you claim a drug-like effect, you must meet drug-like standards.

• Permitted: "Nourishes the scalp," "maintains moisture balance," "supports a healthy environment for hair growth"
• Not permitted: "Prevents thinning," "reverses hair loss," "clinically proven to regrow hair"
• Grey zone: "Encourages fuller-looking hair" (often allowed if presented as appearance, not biology)

Cosmetic status also offers formulation flexibility. Without a mandatory active-ingredient gate, brands can experiment with novel botanicals, adjust concentrations freely, and iterate quickly. That agility can be an advantage when consumer preferences shift or new research emerges on gentle actives that fall outside the quasi-drug ingredient list.

Active ingredients vs botanical actives: how formulation strategy differs

The regulatory split shapes ingredient selection in predictable ways. Quasi-drug formulas anchor on one or more approved actives, then build a supporting cast of emollients, penetration enhancers, and preservatives around that core. Cosmetic formulas often center on botanical extracts (ginseng, camellia, seaweed polysaccharides) that address scalp health through antioxidant, anti-inflammatory, or hydration pathways rather than a single pharmacological lever.

Kiwabi's Scalp Hair Essence illustrates the cosmetic path. It combines Japanese botanical extracts with amino acids and hydrating actives to support the scalp environment without relying on a single high-concentration pharmaceutical ingredient. The result is a formula that prioritizes long-term scalp comfort and barrier health, positioning itself as a complement to (not a replacement for) medical-grade treatments when those are warranted.

5 Japanese scalp serums across the regulatory spectrum (2026)

To ground the regulatory distinction in real products, the table below presents five Japanese scalp serums representative of both categories. Each entry notes regulatory status, flagship actives, permitted claim language, and approximate retail price as of early 2026.

Price variation within each category is significant. Shiseido's Adenovital carries a premium partly because of proprietary research and brand heritage; Kaminomoto offers quasi-drug efficacy at a more accessible entry point. Among cosmetics, Kiwabi's higher price reflects import positioning and a botanical formulation philosophy that prioritizes gentle, long-term scalp support over immediate sensory impact.

Where Kiwabi's botanical formula fits in this landscape

Kiwabi's Scalp Hair Essence sits firmly in the cosmetic category. It does not carry quasi-drug approval, which means it cannot print "prevents hair loss" on the label. What it does instead is build a formulation around Japanese botanical extracts, amino acids, and hydrating actives that address the scalp environment as a whole. The logic is indirect: create conditions where the scalp is balanced, comfortable, and well-nourished, and hair is more likely to grow in a healthy pattern.

That approach aligns with the scalp-as-skin philosophy common in Japanese haircare. Rather than targeting a single biological pathway with a high-concentration active, the formula layers gentle actives that support barrier function, reduce inflammation, and deliver moisture where it's needed. For users with sensitive scalps or those who've experienced irritation from medicated treatments, this can be a more comfortable long-term option. Scalp Hair Essence for Thinning-Prone Hair – Leave-In Serum That Nourishes & Supports Fuller-Looking Hair

• Dual-action design: supports both hair growth and scalp health in a single leave-in formula
• Botanical-first ingredient deck: prioritizes gentle actives over synthetic high-concentration compounds
• No quasi-drug claims: the brand does not promise prevention or regrowth; instead, it speaks to nourishment, strengthening, and environmental support
• Suitable for men and women: formulation does not carry gender-specific actives, making it a flexible choice across hair types

If you're already using a quasi-drug treatment and want to add a gentler supporting product, Kiwabi's Scalp Hair Essence can layer in without conflict. If you're seeking a standalone option that emphasizes scalp comfort over aggressive intervention, it occupies that niche by design.

How to read Japanese product labels for regulatory status

Decoding a Japanese scalp serum label takes less than thirty seconds once you know the visual markers. Most quasi-drugs display 医薬部外品 in a rectangular box near the product name or barcode. English-market versions may print "medicated" or "quasi-drug" in Roman script. Cosmetics carry no special badge; absence of the designation is the signal.

• Look for the 医薬部外品 box: usually printed on the front panel or side of the carton, often in a contrasting color or outlined frame.
• Check the ingredient list order: in Japan, actives in quasi-drugs are often listed first or flagged with an asterisk; cosmetics follow descending-concentration order without special markers.
• Read the claim language carefully: if the package says "prevents," "treats," or "clinically proven to regrow," it must be a quasi-drug. If it says "supports," "nourishes," or "maintains," it's likely a cosmetic.
• Cross-reference the brand's product page: reputable brands will state regulatory status in the product description or FAQ.
• When in doubt, search the product name + 医薬部外品: a quick web search will surface the official classification in Japanese or English.

Be cautious of English translations that overreach. Some gray-market sellers translate cosmetic claim language into stronger terms than the Japanese original permits. If a product marketed as "clinically proven" lacks the 医薬部外品 designation, the claim is either mistranslated or misleading.

Frequently asked questions

Does quasi-drug status guarantee better results than a cosmetic formula?

Not automatically. Quasi-drug approval confirms that the product met an efficacy threshold under specific test conditions, but individual response varies. Scalp sensitivity, consistency of use, and underlying cause of hair thinning all influence outcomes. A well-formulated cosmetic that you use comfortably every day may outperform a quasi-drug that irritates your scalp and ends up half-empty in the bathroom drawer.

Can I use a quasi-drug and a cosmetic scalp serum together?

Yes, in most cases. Many users layer a quasi-drug treatment (applied to areas of concern) with a cosmetic serum (used more broadly for scalp maintenance). Check ingredient overlap; if both contain glycyrrhizic acid derivatives or other shared actives, total exposure may exceed intended levels. When in doubt, apply the quasi-drug first, let it absorb fully, then follow with the cosmetic formula.

Are quasi-drugs more likely to cause scalp irritation?

They can be, but it depends on the specific active and your scalp's tolerance. Minoxidil, for example, is known to cause dryness or flaking in some users. Adenosine and β-glycyrrhetinic acid are generally well-tolerated. Ethanol (a common solvent in medicated serums) can sting on sensitive or compromised scalps. If irritation is a concern, starting with a cosmetic formula may be the gentler entry point.

How long does it take to see results from either category?

For quasi-drugs, clinical trials often report measurable changes at 12 to 16 weeks. Cosmetic formulas do not carry standardized timelines, but most brands recommend consistent use for at least 8 to 12 weeks before assessing scalp comfort and hair appearance. Hair growth cycles move slowly; expecting visible change in less than two months is unrealistic regardless of regulatory category.

Are Japanese scalp serums safe during pregnancy?

Safety depends on the specific ingredients, not the regulatory category. Minoxidil-containing quasi-drugs are generally contraindicated during pregnancy. Many botanical cosmetics are considered low-risk, but individual ingredients (e.g., certain essential oils) may carry precautions. Always consult your healthcare provider before starting any new scalp treatment during pregnancy or breastfeeding.

Do cosmetic scalp serums need to be applied as frequently as quasi-drugs?

Usage frequency varies by product, not category. Some quasi-drugs recommend twice-daily application; others, once daily. Cosmetic serums likewise range from daily to every-other-day use. Follow the brand's specific instructions and adjust based on your scalp's response. Overuse does not accelerate results and can lead to product buildup or irritation.

Can I tell from the ingredient list alone whether a product is a quasi-drug?

Not definitively. While the presence of adenosine, minoxidil, or other known actives suggests quasi-drug status, some cosmetics also include these ingredients at sub-threshold concentrations. The only reliable marker is the 医薬部外品 label or an explicit "medicated" statement from the brand. Ingredient lists alone can mislead.

Are quasi-drugs available outside Japan, or do I need to import them?

Japanese quasi-drug approval is domestic; these products are not automatically cleared for sale in the US, EU, or other markets. Some brands pursue separate regulatory approval abroad (e.g., FDA registration in the US), but many quasi-drugs remain Japan-exclusive or are sold internationally as cosmetics with modified claim language. If you're ordering from a non-Japanese retailer, verify whether the product retains its original quasi-drug formulation or has been reformulated for export.

Related reading

• Can I Use Hair Growth Products If I Have A Sensitive Scalp
• Can Scalp Massage Really Help With Hair Growth
• What Is Japanese Scalp Care